Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

• Main Authors: Verdoia, Monica, Suryapranata, Harry, Damen, Sander, Camaro, Cyril, Benit, Edouard., Barbieri, Lucia, Rasoul, Saman, Liew, Houng Bang, Polad, Jawed, Wan Ahmad, Wan Azman, Zambahari, Robaayah, Lalmand, Jacques, van der Schaaf, Renè J., Koh, Tian Hai, Timmermans, Philippe, Dilling-Boer, Dagmara, Veenstra, Leo F., Van't Hof, Arnoud W. J., Lee, Stephen Wai Luen, Roolvink, Vincent, Ligtenberg, Erik, Postma, Sonja, Kolkman, Evelien J. J., Brouwer, Marc A., Kedhi, Elvin, De Luca, Giuseppe
• Format: Article
• Published: Springer 2021
• Subjects: R Medicine
• Online Access: http://eprints.um.edu.my/34674/

Background Gender differences in the thrombotic and bleeding risk have been suggested to condition the benefits of antithrombotic therapies in Acute Coronary Syndrome (ACS) patients, and mainly among those undergoing percutaneous coronary interventions with drug eluting stents (DES). The impact of g...